Immune Repertoire Sequencing Market By Sequencing Platform, Application and End User - Global Industry Analysis And Forecast To 2027
Published On : January 2019 Pages : 150 Category: Biotechnology Report Code : HC012245
Immune Repertoire Sequencing Market By Sequencing Platform (Semiconductor Sequencing, Pyro-Sequencing, Dye-Terminating Sequencing and Other Sequencing Platforms), Application (Transplant Rejection & Tolerance, Vaccine Development & Efficacy, Biomarker Discovery, Autoimmune Disease, Infectious Diseases, Cancer Immunotherapy and Other Applications) and End User (Research Centers, Diagnostic Labs and Other End Users) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Immune Repertoire is known as the sum of number of T cell & B cell receptors that overall designs the immune system of an organism. Immune Repertoire Sequencing procedure is used by scientists & researchers for the study & understanding the adaptive immune-medicated disorders. Immune Repertoire Sequencing is also has wide applications in infectious disease research, biomarker discovery, cancer immunotherapy, asthma & allergy research, etc. Use of Immune Repertoire Sequencing is growing due to; growing R&D for product development, increased number of launch of novel products, increasing number of cases related to cancer, increase in government funding, wide range of applications of the technique, etc. Therefore, the Immune Repertoire Sequencing Market is anticipated to expand and has tremendous scope during the forecast period. The global Immune Repertoire Sequencing Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Immune Repertoire Sequencing Market is based on segment, by Sequencing Platform the market is segmented into Semiconductor Sequencing, Pyro-Sequencing, Dye-Terminating Sequencing and Other Sequencing Platforms, by Application the market is segmented into Transplant Rejection & Tolerance, Vaccine Development & Efficacy, Biomarker Discovery, Autoimmune Disease, Infectious Diseases, Cancer Immunotherapy and Other Applications, and by End User the market is segmented into Research Centers, Diagnostic Labs and Other End Users.
- Immune Repertoire Sequencing Market, By Sequencing Platform
- Semiconductor Sequencing
- Pyro-Sequencing
- Dye-Terminating Sequencing
- Other Sequencing Platforms
- Immune Repertoire Sequencing Market, By Application
- Transplant Rejection & Tolerance
- Vaccine Development & Efficacy
- Biomarker Discovery
- Autoimmune Disease
- Infectious Diseases
- Cancer Immunotherapy
- Other Applications
- Immune Repertoire Sequencing Market, By End User
- Research Centers
- Diagnostic Labs
- Other End Users
Regional Insights
On a global front, the Immune Repertoire Sequencing Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).North American region is leading the Immune Repertoire Sequencing Market followed by European region owing to technical development & more number of skilled medical professionals in the regions.
Immune Repertoire Sequencing Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Adaptive Biotechnologies, Pacific Biosciences, ArcherDX Inc., ThermoFisher Scietific, Juno Therapeutics, Atreca Inc., CD Genomics, Roche Holding AG and Illumina Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Adaptive Biotechnologies
- Pacific Biosciences
- ArcherDX Inc.
- ThermoFisher Scietific
- Juno Therapeutics
- Atreca Inc.
- CD Genomics
- Roche Holding AG
- Illumina Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Immune Repertoire Sequencing Market, By Sequencing Platform, Estimates and Forecast, 2017-2027 ($Million)
o Semiconductor Sequencing
o Pyro-Sequencing
o Dye-Terminating Sequencing
o Other Sequencing Platforms
· Immune Repertoire Sequencing Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Transplant Rejection & Tolerance
o Vaccine Development & Efficacy
o Biomarker Discovery
o Autoimmune Disease
o Infectious Diseases
o Cancer Immunotherapy
o Other Applications
· Immune Repertoire Sequencing Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Research Centers
o Diagnostic Labs
o Other End Users
· Immune Repertoire Sequencing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Immune Repertoire Sequencing Market, By Country
o U.S. Immune Repertoire Sequencing Market
o Canada Immune Repertoire Sequencing Market
o Mexico Immune Repertoire Sequencing Market
o Europe
§ Europe Immune Repertoire Sequencing Market, By Country
o Germany Immune Repertoire Sequencing Market
o UK Immune Repertoire Sequencing Market
o France Immune Repertoire Sequencing Market
o Russia Immune Repertoire Sequencing Market
o Italy Immune Repertoire Sequencing Market
o Rest of Europe Immune Repertoire Sequencing Market
o Asia-Pacific
§ Asia-Pacific Immune Repertoire Sequencing Market, By Country
o China Immune Repertoire Sequencing Market
o Japan Immune Repertoire Sequencing Market
o South Korea Immune Repertoire Sequencing Market
o India Immune Repertoire Sequencing Market
o Southeast Asia Immune Repertoire Sequencing Market
o Rest of Asia-Pacific Immune Repertoire Sequencing Market
o South America
§ South America Immune Repertoire Sequencing Market, By Country
o Brazil Immune Repertoire Sequencing Market
o Argentina Immune Repertoire Sequencing Market
o Columbia Immune Repertoire Sequencing Market
o Rest of South America Immune Repertoire Sequencing Market
o Middle East and Africa
§ Middle East and Africa Immune Repertoire Sequencing Market, By Country
o Saudi Arabia Immune Repertoire Sequencing Market
o UAE Immune Repertoire Sequencing Market
o Egypt Immune Repertoire Sequencing Market
o Nigeria Immune Repertoire Sequencing Market
o South Africa Immune Repertoire Sequencing Market
o Rest of MEA Immune Repertoire Sequencing Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Immune Repertoire Sequencing Market, By Sequencing Platform
5.1. Introduction
5.2. Global Immune Repertoire Sequencing Revenue and Market Share by Sequencing Platform (2017-2027)
5.2.1. Global Immune Repertoire Sequencing Revenue and Revenue Share by Sequencing Platform (2017-2027)
5.3. Semiconductor Sequencing
5.3.1. Global Semiconductor Sequencing Revenue and Growth Rate (2017-2027)
5.4. Pyro-Sequencing
5.4.1. Global Pyro-Sequencing Revenue and Growth Rate (2017-2027)
5.5. Dye-Terminating Sequencing
5.5.1. Global Dye-Terminating Sequencing Revenue and Growth Rate (2017-2027)
5.6. Other Sequencing Platforms
5.6.1. Global Other Sequencing Platforms Revenue and Growth Rate (2017-2027)
6. Immune Repertoire Sequencing Market, By Application
6.1. Introduction
6.2. Global Immune Repertoire Sequencing Revenue and Market Share by Application (2017-2027)
6.2.1. Global Immune Repertoire Sequencing Revenue and Revenue Share by Application (2017-2027)
6.3. Transplant Rejection & Tolerance
6.3.1. Global Transplant Rejection & Tolerance Revenue and Growth Rate (2017-2027)
6.4. Vaccine Development & Efficacy
6.4.1. Global Vaccine Development & Efficacy Revenue and Growth Rate (2017-2027)
6.5. Biomarker Discovery
6.5.1. Global Biomarker Discovery Revenue and Growth Rate (2017-2027)
6.6. Autoimmune Disease
6.6.1. Global Autoimmune Disease Revenue and Growth Rate (2017-2027)
6.7. Infectious Diseases
6.7.1. Global Infectious Diseases Revenue and Growth Rate (2017-2027)
6.8. Cancer Immunotherapy
6.8.1. Global Cancer Immunotherapy Revenue and Growth Rate (2017-2027)
6.9. Other Applications
6.9.1. Global Other Applications Revenue and Growth Rate (2017-2027)
7. Immune Repertoire Sequencing Market, By End User
7.1. Introduction
7.2. Global Immune Repertoire Sequencing Revenue and Market Share by End User (2017-2027)
7.2.1. Global Immune Repertoire Sequencing Revenue and Revenue Share by End User (2017-2027)
7.3. Research Centers
7.3.1. Global Research Centers Revenue and Growth Rate (2017-2027)
7.4. Diagnostic Labs
7.4.1. Global Diagnostic Labs Revenue and Growth Rate (2017-2027)
7.5. Other End Users
7.5.1. Global Other End Users Revenue and Growth Rate (2017-2027)
8. Immune Repertoire Sequencing Market, By Region
8.1. Introduction
8.2. Global Immune Repertoire Sequencing Revenue and Market Share by Regions
8.2.1. Global Immune Repertoire Sequencing Revenue by Regions (2017-2027)
8.3. North America Immune Repertoire Sequencing by Countries
8.3.1. North America Immune Repertoire Sequencing Revenue and Growth Rate (2017-2027)
8.3.2. North America Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Immune Repertoire Sequencing by Countries
8.4.1. Europe Immune Repertoire Sequencing Revenue and Growth Rate (2017-2027)
8.4.2. Europe Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Immune Repertoire Sequencing by Countries
8.5.1. Asia-Pacific Immune Repertoire Sequencing Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Immune Repertoire Sequencing by Countries
8.6.1. South America Immune Repertoire Sequencing Revenue and Growth Rate (2017-2027)
8.6.2. South America Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Immune Repertoire Sequencing by Countries
8.7.1. Middle East and Africa Immune Repertoire Sequencing Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Adaptive Biotechnologies
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Pacific Biosciences
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. ArcherDX Inc.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. ThermoFisher Scietific
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Juno Therapeutics
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Atreca Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. CD Genomics
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Roche Holding AG
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Illumina Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
10. Global Immune Repertoire Sequencing Market Competition, by Manufacturer
10.1. Global Immune Repertoire Sequencing Revenue and Market Share by Manufacturer (2017-2017)
10.2. Top 5 Immune Repertoire Sequencing Manufacturer Market Share
10.3. Market Competition Trend
11. Immune Repertoire Sequencing Market Forecast (2017-2027)
11.1. Global Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Immune Repertoire Sequencing Market Forecast by Regions (2017-2027)
11.2.1. North America Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.1.1. United States Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.1.2. Canada Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.1.3. Mexico Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.2. Europe Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.2.1. Germany Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.2.2. France Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.2.3. UK Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.2.4. Russia Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.2.5. Italy Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.3. Asia-Pacific Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.3.1. China Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.3.2. Japan Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.3.3. Korea Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.3.4. India Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.4. South America Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.4.1. Brazil Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.4.2. Argentina Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.4.3. Columbia Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.4.4. Rest of South America Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5. Middle East and Africa Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5.3. Egypt Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5.4. Nigeria Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5.5. South Africa Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5.6. Turkey Immune Repertoire Sequencing Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Immune Repertoire Sequencing Market Forecast (2017-2027)
11.3. Immune Repertoire Sequencing Market Forecast by Sequencing Platform (2017-2027)
11.3.1. Immune Repertoire Sequencing Forecast by Sequencing Platform (2017-2027)
11.3.2. Immune Repertoire Sequencing Market Share Forecast by Sequencing Platform (2017-2027)
11.4. Immune Repertoire Sequencing Market Forecast by Application (2017-2027)
11.4.1. Immune Repertoire Sequencing Forecast by Application (2017-2027)
11.4.2. Immune Repertoire Sequencing Market Share Forecast by Application (2017-2027)
11.5. Immune Repertoire Sequencing Market Forecast by End User (2017-2027)
11.5.1. Immune Repertoire Sequencing Forecast by End User (2017-2027)
11.5.2. Immune Repertoire Sequencing Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Immune Repertoire Sequencing Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Immune Repertoire Sequencing Revenue and Revenue Share by Sequencing Platform (2017-2018)
Figure Global Semiconductor Sequencing Revenue and Growth Rate (2017-2018)
Figure Global Pyro-Sequencing Revenue and Growth Rate (2017-2018)
Figure Global Dye-Terminating Sequencing Revenue and Growth Rate (2017-2018)
Figure Global Other Sequencing Platforms Revenue and Growth Rate (2017-2018)
Table Global Immune Repertoire Sequencing Revenue and Revenue Share by Application (2017-2018)
Figure Global Transplant Rejection & Tolerance Revenue and Growth Rate (2017-2018)
Figure Global Vaccine Development & Efficacy Revenue and Growth Rate (2017-2018)
Figure Global Biomarker Discovery Revenue and Growth Rate (2017-2018)
Figure Global Autoimmune Disease Revenue and Growth Rate (2017-2018)
Figure Global Infectious Diseases Revenue and Growth Rate (2017-2018)
Figure Global Cancer Immunotherapy Revenue and Growth Rate (2017-2018)
Figure Global Other Applications Revenue and Growth Rate (2017-2018)
Table Global Immune Repertoire Sequencing Revenue and Revenue Share by End User (2017-2018)
Figure Global Research Centers Revenue and Growth Rate (2017-2018)
Figure Global Diagnostic Labs Revenue and Growth Rate (2017-2018)
Figure Global Other End Users Revenue and Growth Rate (2017-2018)
Table Global Immune Repertoire Sequencing Revenue by Regions (2017-2018)
Figure North America Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure North America Immune Repertoire Sequencing Revenue and Growth Rate (2017-2018)
Figure North America Immune Repertoire Sequencing by Countries (2017-2018)
Figure North America Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2018)
Figure United States Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure United States Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Canada Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Mexico Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Europe Immune Repertoire Sequencing Revenue and Growth Rate (2017-2018)
Figure Europe Immune Repertoire Sequencing by Countries (2017-2018)
Figure Europe Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2018)
Figure Germany Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Germany Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure France Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure UK Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Russia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Italy Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Rest of Europe Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Asia-Pacific Immune Repertoire Sequencing Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Immune Repertoire Sequencing by Countries (2017-2018)
Figure Asia-Pacific Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2018)
Figure China Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure China Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Japan Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Korea Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure India Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Southeast Asia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure South America Immune Repertoire Sequencing Revenue and Growth Rate (2017-2018)
Figure South America Immune Repertoire Sequencing by Countries (2017-2018)
Figure South America Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Brazil Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Argentina Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Columbia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Rest of South America Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Middle East and Africa Immune Repertoire Sequencing Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Immune Repertoire Sequencing by Countries (2017-2018)
Figure Middle East and Africa Immune Repertoire Sequencing Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Saudi Arabia Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure United Arab Emirates Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Egypt Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Nigeria Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure South Africa Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Turkey Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immune Repertoire Sequencing Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2017-2018)
Table Adaptive Biotechnologies Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pacific Biosciences Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ArcherDX Inc. Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ThermoFisher Scietific Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Juno Therapeutics Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Atreca Inc. Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CD Genomics Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Holding AG Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Illumina Inc. Immune Repertoire Sequencing Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Immune Repertoire Sequencing Market Share by Manufacturer
Figure Global Immune Repertoire Sequencing Revenue and Market Share by Manufacturer
Table Global Immune Repertoire Sequencing Price by Region (2017-2017)
Figure Top 5 Immune Repertoire Sequencing Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Immune Repertoire Sequencing Revenue (Millions USD) and Growth Rate (2018-2025)
Table Immune Repertoire Sequencing Market Forecast by Regions (2018-2025)
Figure North America Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure United States Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Canada Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Mexico Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Europe Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Germany Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure France Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure UK Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Russia Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Italy Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Rest of Europe Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Asia-Pacific Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure China Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Japan Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Korea Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure India Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Southeast Asia Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure South America Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Brazil Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Argentina Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Columbia Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Rest of South America Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Middle East and Africa Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Saudi Arabia Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure United Arab Emirates Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Egypt Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Nigeria Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure South Africa Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Turkey Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Immune Repertoire Sequencing Market Forecast (2018-2025)
Figure Global Immune Repertoire Sequencing Forecast by Sequencing Platform (2018-2025)
Figure Global Immune Repertoire Sequencing Market Share Forecast by Sequencing Platform (2018-2025)
Figure Global Immune Repertoire Sequencing Forecast by Sequencing Platform (2018-2025)
Figure Global Immune Repertoire Sequencing Forecast by Application (2018-2025)
Figure Global Immune Repertoire Sequencing Market Share Forecast by Application (2018-2025)
Figure Global Immune Repertoire Sequencing Forecast by Application (2018-2025)
Figure Global Immune Repertoire Sequencing Forecast by End User (2018-2025)
Figure Global Immune Repertoire Sequencing Market Share Forecast by End User (2018-2025)
Figure Global Immune Repertoire Sequencing Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|